NCT04732728已完成不适用
LUX-Dx Insertable Cardiac Monitor Remote Programming and Performance Study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 727
- 试验地点
- 24
- 主要终点
- ICM System-related Complication-free Rate at 30 Days Post-implant
研究概览
简要总结
The LUX-Dx PERFORM Study had two primary objects which were (1) to characterize, in a general patient population, the utilization of the remote programming feature of the Boston Scientific (BSC) Insertable Cardiac Monitor (ICM) device and (2) to collect data to characterize the performance of arrhythmia detection algorithms. Data was also collected to characterize the ICM system related safety events.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Patient is indicated to be implanted with the LUX-Dx ICM for one of the following reasons (grouped in three "Reason for Monitoring" subgroups): 1) Cryptogenic stroke, 2) Syncope, 3) AF management, Post-AF ablation, or Suspected AF
- •Patient is willing to enroll and be monitored in LATITUDE Clarity.
- •Patient is willing and able to be followed remotely via the ICM patient mobile app.
- •Patient is willing and capable of providing informed consent (which is not to include the use of a legally authorized representative (LAR) for documentation of informed consent) and agrees to participate in all protocol required activities.
- •Patient is age 18 years or above, or of legal age to give informed consent specific to state and national law.
- •The following inclusion criterion is applicable for patients participating in the Holter study:
- •Patient can tolerate the adhesive used in the Holter monitoring for an extended period of time.
排除标准
- •Patient is indicated for implantation of, or is currently implanted with an active implantable cardiac device (e.g., LVAD, ICD, CRT D, PPM*).
- •Patient cannot tolerate a subcutaneous, chronically-inserted device due to medical condition.
- •Patient has a documented life expectancy of less than 12 months (per investigator's discretion).
- •Patient is known to be pregnant at the time of study enrollment (method of assessment upon investigator's discretion).
- •Patient is currently enrolled in another clinical study including observational studies/registries, unless prior written approval from BSC is obtained. Mandatory governmental registries are accepted for co-enrollment without approval by BSC.
- •The following exclusion criteria are applicable for patients participating in the Holter study:
- •Patient has known allergies to the adhesive materials or hydrogel used in the extended Holter monitoring.
- •Patient has broken, damaged, or irritated skin over the chest area where the extended Holter monitor will be attached.
结局指标
主要结局
ICM System-related Complication-free Rate at 30 Days Post-implant
时间窗: 30 days
ICM System-related Complication-free Rate at 12 Months Post-implant
时间窗: 12 months
次要结局
未报告次要终点
研究者
研究点 (24)
Loading locations...
相似试验
已完成
不适用
LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System.Heart FailureNCT04790344Boston Scientific Corporation557
尚未招募
不适用
Performance Evaluation of Lucie™ for Hydration of Dialysis PatientsDiabetesNCT06640270Home Habilis150
已完成
不适用
Profiling Implantable Cardiac Device Diagnostics Trends During Clinical Events .Cardiovascular DiseasesNCT03091959Medtronic Cardiac Rhythm and Heart Failure200
招募中
不适用
Interest of Two Digital Devices for the Diagnosis of Neurocognitive Disorders in Elderly People With Cognitive Symptoms.Age-related Cognitive DeclineComputers, HandheldNeurocognitive DisordersNCT06032611RIVAGES150
已完成
不适用
Heart and Lung Function Monitoring SystemHeart DiseasesLung DiseasesNCT02168049University of California, Los Angeles150